Skip to main content

Latest News

NICE approves use of new treatment for advanced metastatic bladder cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line treatment for untreated unresectable or metastatic urothelial (bladder) cancer in patients who are eligible for platinum-based chemotherapy. Urothelial cancer affects cells that form the inner...

Upcoming Event

8 Sep 2025

Urogynaecology & Urology Procedues

The ICENI Centre, Colchester Hospital, Turner Road, Colchester CO4 5JL

Aimed to develop or refresh ambulatory skills of urology and urogynaecology consultants, trainees and specialist nurses. **Change of date and course fee** Course content This one-day event is an excellent opportunity to enhance your understanding of the full spectrum of ambulatory urogynaecology/urology procedures including the basics,...